Using legacy and current data to accelerate drug development As the pharmaceutical industry faces rising research and development costs (R&D) costs per drug brought…Ben.frew@excelra.comApril 16, 2022 Read More
Key aspects of building a predictive analytics engine Growth in technology has been attributed to the strong association between computational power and Big…Ben.frew@excelra.comApril 15, 2022 Read More
Interview with Anandbir Singh Brar, chief executive officer, Excelra I have been involved with Excelra right from its inception in 2014 as part of…Ben.frew@excelra.comApril 15, 2022 Read More
Integrated text mining and data curation approaches for biomedical knowledgebase development The conversion of unstructured data into high-quality actionable insights based on information retrieval, data mining,…Ben.frew@excelra.comApril 15, 2022 Read More
G-protein coupled receptors: structures, research landscape and trends G protein-coupled receptors (GPCRs) have become a hot frontier in basic research of life sciences…Ben.frew@excelra.comApril 15, 2022 Read More
Drug target dossier: target intelligence for data-driven drug discovery Drug discovery and development is a long, expensive and risky process. On average it takes…Ben.frew@excelra.comApril 14, 2022 Read More
Digitization and data science in drug discovery It is amply clear that digitization and utilization of data science is playing an important…Ben.frew@excelra.comApril 14, 2022 Read More
Data-driven drug repurposing “Pharma is taking a more of a data-driven and strategic approach to Drug Repurposing,” says…Ben.frew@excelra.comApril 14, 2022 Read More
Biologics – the biotech drugs transforming medicine Biologics, also known as biological products, are any type of medicines derived from living organisms…Ben.frew@excelra.comMarch 15, 2022 Read More
Life Sciences Tech Trends 2021 COVID-19 has had an unprecedented adverse impact on global health and economy at large. While…Ben.frew@excelra.comApril 16, 2021 Read More